Sort by:
Keyphrases
Sclerostin
100%
Aptamer
91%
Bone Formation
76%
Osteoblastic
37%
Paclitaxel
37%
Pancreatic Ductal Adenocarcinoma
37%
In Cancer
33%
Osteoblast
30%
Inflammation
28%
Protective Behavior
28%
MicroRNA
26%
ApoER2
26%
Nucleic Acids
25%
Programmed Death-ligand 1 (PD-L1)
25%
BMP Signaling
25%
Rheumatoid Arthritis
25%
Smad
25%
Breast Cancer Bone Metastasis
25%
Pancreatic Cancer
25%
Drug Discovery
25%
Molecular Understanding
25%
Triple-negative Breast Cancer
25%
Cardiovascular Protective
25%
Tumor Microenvironment
24%
Therapeutic Strategies
21%
Breast Cancer
20%
Binding Affinity
19%
Osteoclast
19%
Therapeutic Target
19%
Osteogenesis Imperfecta
18%
Therapeutic Use
18%
Tumor Progression
18%
Tumor Cells
18%
Tumor
18%
Breast Cancer Patients
17%
Inflammatory Response
16%
Confidence Interval
16%
Triple-negative Breast Cancer Cells
16%
Cardiovascular Risk
16%
Nucleic Acid Aptamer
15%
Cancer Immunotherapy
15%
Tumor Targeting
15%
Targeted Therapy
15%
Small Molecules
15%
Chemical Modification
15%
Mini
14%
Smurf1
14%
Wnt Signaling
14%
Aging
14%
Mouse Model
14%
Oligonucleotides
13%
Tumor Metastasis
13%
Chemotherapy
13%
Sclerostin Inhibitor
13%
Hypoxia-inducible factor-1α (HIF-1α)
12%
Cell-SELEX
12%
Leflunomide
12%
Bone Erosion
12%
Antineoplastic Drugs
12%
Gain Cell
12%
PD-L1 Aptamers
12%
Ovarian Cancer
12%
Nucleolin Aptamer
12%
Osteolytic Metastasis
12%
MiR-214-3p
12%
Rare Bone Disease
12%
Therapeutic Perspectives
12%
Receptor Activator of nuclear factor-κB Ligand (RANKL)
12%
Lipopolymer
12%
Therapeutic Genome Editing
12%
Age-related Osteoporosis
12%
Phosphorus Metabolism
12%
PARP Inhibitor (PARPi)
12%
Aptamer Targeting
12%
Immune Checkpoint
12%
Shuttling Protein
12%
Nucleocytoplasmic Shuttling
12%
Carcinoma
12%
Vinorelbine
12%
Huaier Granule
12%
Immune System
12%
Systems-based
12%
Inflammatory Genes
12%
Water-soluble
12%
Vascular Endothelial Growth Factor
12%
MiRNA-mRNA Interaction
12%
Casein Kinase 2 Interacting protein-1 (CKIP-1)
12%
Structure Determination
12%
Joint Inflammation
12%
Extracellular Vesicles
12%
Gene Network
12%
Interleukin-17 (IL-17)
12%
Cancer Targeting
12%
Targeted Therapeutics
12%
Immune-related
12%
Molecular Therapeutics
12%
Single Center
12%
Targeting Strategies
12%
Cas9 Protein
12%
Inflammatory Process
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sclerostin
87%
Aptamer
75%
Breast Cancer
39%
Neoplasm
34%
Malignant Neoplasm
32%
Drug Discovery
28%
Nucleic Acid
25%
Bone Metastasis
25%
Paclitaxel
25%
Osteogenesis Imperfecta
18%
microRNA
17%
Cardiovascular Risk
17%
Inflammation
16%
Tumor Growth
15%
Messenger RNA
15%
Bone Disease
14%
Monoclonal Antibody
13%
Chemotherapy
13%
Retrospective Study
12%
Rheumatoid Arthritis
12%
Inflammatory Arthritis
12%
Bone Erosion
12%
Leflunomide
12%
Nucleolin
12%
Triple Negative Breast Cancer
12%
microRNA 214
12%
Pancreas Cancer
12%
Programmed Death 1 Ligand 1
12%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
12%
Vinorelbine
12%
Carcinoma
12%
Tumor Necrosis Factor Receptor Associated Factor 3
12%
Ovary Cancer
12%
Vasculotropin A
12%
Osteoclast Differentiation Factor
12%
Lung Cancer
12%
Immunotherapy
12%
Osteosarcoma
12%
Perineural Invasion
12%
Pancreas Adenocarcinoma
12%
Apolipoprotein E Knockout Mouse
11%
Diseases
8%
Survival Rate
7%
Overall Survival
7%
Disease Free Survival
7%
Clinical Trial
6%
Immunogenicity
6%
Tumor Microenvironment
5%
Receptor
5%
Aortic Aneurysm
5%
Nanoparticle
5%
Lung Metastasis
5%
X-Linked Hypophosphatemia
5%
Mouse Model
5%
Medicine and Dentistry
Aptamer
45%
Breast Cancer
37%
Ossification
26%
Tumor Microenvironment
25%
Bone Metastasis
25%
Sclerostin
25%
Pancreas Adenocarcinoma
25%
Malignant Neoplasm
18%
Osteoclast
18%
microRNA
17%
Targeted Therapy
15%
Cardiovascular System
15%
Tumor Cell
15%
Bone Morphogenetic Protein
12%
Metabolomics
12%
Tumor Necrosis Factor Receptor Associated Factor 3
12%
Osteoporosis
12%
Pancreas Cancer
12%
Disorders of Calcium Metabolism
12%
Phosphate Metabolism
12%
Proteomics
12%
Programmed Death-Ligand 1
12%
Triple Negative Breast Cancer
12%
Cancer Associated Fibroblast
12%
Osteoclast Differentiation Factor
12%
Vasculotropin A
12%
Clustered Regularly Interspaced Short Palindromic Repeat
12%
Chemokine
12%
microRNA 214
12%
Nucleic Acid
12%
Cas9
12%
Genome Editing
12%
Osteosarcoma
12%
Carcinoma
12%
Paclitaxel
12%
Chondrocyte
12%
Osteoarthritis
12%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
12%
Alpha 1 Antitrypsin
12%
Perineural Invasion
12%
Schwann Cell
12%
Proteinase Inhibitor
12%
Retrospective Study
12%
Propensity Score Matching
12%
Cancer Cell
10%
Tumor
9%
Cancer
8%
Metastatic Carcinoma
8%
RNA Sequencing
7%
Biological Marker
7%
Survival Rate
7%
Hazard Ratio
7%
Disease Free Survival
7%
Overall Survival
7%
Monoclonal Antibody
6%
Cancer Therapy
6%
Receptor
6%
Fibroblast Growth Factor 23
6%
Parathyroid Hormone
6%
Isotopes of Calcium
6%
Spinal Fusion
5%
Chalcone Derivative
5%
Bone Morphogenetic Protein 2
5%
Cardiovascular System
5%
Lung Metastasis
5%
Angiogenesis
5%